gms | German Medical Science

64th Annual Meeting of the German Society of Neurosurgery (DGNC)

German Society of Neurosurgery (DGNC)

26 - 29 May 2013, Düsseldorf

MicroRNAs located on 10q23-qter as tumor suppressor candidates in astrocytic gliomas

Meeting Abstract

Search Medline for

  • Thomas Werner - Klinik für Allgemein-, Viszeral- und Kinderchirurgie, Heinrich Heine Universität, Düsseldorf
  • Marietta Wolter - Institut für Neurochirurgie, Heinrich Heine Universität, Düsseldorf
  • Guido Reifenberger - Institut für Neurochirurgie, Heinrich Heine Universität, Düsseldorf

Deutsche Gesellschaft für Neurochirurgie. 64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Düsseldorf, 26.-29.05.2013. Düsseldorf: German Medical Science GMS Publishing House; 2013. DocP 144

doi: 10.3205/13dgnc561, urn:nbn:de:0183-13dgnc5617

Published: May 21, 2013

© 2013 Werner et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Objective: Deletions of chromosome 10 are among the most common genetic alterations in glioblastomas. They are found in up to 90% of the cases. Molecular analyses have revealed evidence for several distinct tumor suppressor gene loci at 10p, 10q23 and 10q24-qter, respectively. We were interested in the identification of novel tumor suppressor microRNAs located distal of the known glioblastoma- associated PTEN tumor suppressor gene on 10q23-qter.

Method: Therefore, we screened a series of astrocytic gliomas of different malignancy for the expression of 12 microRNAs located in the respective chromosomal region using real-time reverse-transcriptase-PCR.

Results: We identified three microRNAs (miR-107, miR-146b and miR-346) exhibiting a significant decrease in their expression levels in high grade astrocytic gliomas compared to their expression in normal brain tissue samples. Pyrosequencing of sodium bisulfite-modified DNA revealed hypermethylation of CpG islands located in the miR-346 genomic region in the majority of primary glioblastomas. Hypermethylation correlated inversely with the expression of this miRNA. Over-expression of precursors of each of the three miRNAs in glioma cells influenced cell proliferation and caspase-3/7-activity. Real-time PCR expression analysis, Western blotting and luciferase-reporter gene assays identified CDK6, EGFR, and BCL6 as targets regulated by miR-107, miR-146b or miR-346, respectively.

Conclusions: Taken together, we identified three putative glioma-suppressor candidate microRNAs that are frequently downregulated in high-grade astrocytic gliomas, regulate glioma-associated proto-oncogenes and thus likely play an important role in glioma pathogenesis.